Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1996;43(1):65-76.

Crystal structures of some acyclonucleosides with antiviral activity and related compounds

Affiliations
  • PMID: 8790713
Review

Crystal structures of some acyclonucleosides with antiviral activity and related compounds

K B Birnbaum. Acta Biochim Pol. 1996.

Abstract

The crystal structure of the acyclonucleoside, 9-[4-hydroxy-2-(hydroxymethyl)-butyl]guanine (2HM-HBG), has been compared with related acyclonucleosides, and that of the acyclonucleotide, 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine-3',5'-cyclic phosphate (DHPG-cMP), also with its parent second messenger cGMP and cyclic monophosphate nucleotides. There is considerable conformational flexibility in the acyclic chain of these compounds with several conformations coexisting in the solid state. This flexibility together with the narrow range of the glycosidic torsion angles (from 69 degrees to 94 degrees, with an average of 83(3) degrees for 11 molecules when the aglycon is guanine, and from 92 degrees to 108 degrees with an average of 103(3) degrees for 4 molecules when the aglycon is adenine) may be essential for the antiviral activity of these compounds and their ability to act as substrates. The mechanism of antiviral activity of, 9-[(1,3-dihydroxy-2-propoxy)methyl] guanine-3',5'-cyclic phosphate is different from that of the acyclonucleosides, and is discussed in the light of it being a close structural analogue to the second messenger cGMP.

PubMed Disclaimer

Similar articles